1. Home
  2. ANTX vs GLQ Comparison

ANTX vs GLQ Comparison

Compare ANTX & GLQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

SELL

Current Price

$4.22

Market Cap

172.9M

Sector

Health Care

ML Signal

SELL

Logo Clough Global Equity Fund Clough Global Equity Fund of Beneficial Interest

GLQ

Clough Global Equity Fund Clough Global Equity Fund of Beneficial Interest

SELL

Current Price

$7.18

Market Cap

142.4M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ANTX
GLQ
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
142.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ANTX
GLQ
Price
$4.22
$7.18
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $9.00
N/A
AVG Volume (30 Days)
★ 236.2K
37.3K
Earning Date
11-09-2026
01-01-0001
Dividend Yield
N/A
★ 11.11%
EPS Growth
★ 32.56
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$7.27
52 Week High
$7.19
$8.75

Technical Indicators

Market Signals
Indicator
ANTX
GLQ
Relative Strength Index (RSI) 49.94 34.23
Support Level $3.89 N/A
Resistance Level $5.11 $7.76
Average True Range (ATR) 0.39 0.16
MACD 0.07 -0.02
Stochastic Oscillator 45.83 2.59

Price Performance

Historical Comparison
ANTX
GLQ

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

About GLQ Clough Global Equity Fund Clough Global Equity Fund of Beneficial Interest

Clough Global Equity Fund is a closed-end management investment company. Its investment objective is to provide a high level of total return. The Fund invests in the equity, equity-related securities, and fixed-income securities in both U.S. and non-U.S. markets.

Share on Social Networks: